Aadi Total Current Liabilities from 2010 to 2024
| AADI Stock | USD 2.28 0.03 1.30% |
Total Current Liabilities | First Reported 2009-06-30 | Previous Quarter 22.1 M | Current Value 15.8 M | Quarterly Volatility 8 M |
Check Aadi Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aadi Bioscience's main balance sheet or income statement drivers, such as Other Operating Expenses of 101.1 M, Total Operating Expenses of 98.2 M or Interest Expense of 224.8 K, as well as many indicators such as Price To Sales Ratio of 2.12, Dividend Yield of 0.0164 or PTB Ratio of 0.54. Aadi financial statements analysis is a perfect complement when working with Aadi Bioscience Valuation or Volatility modules.
Aadi | Total Current Liabilities |
Latest Aadi Bioscience's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Aadi Bioscience over the last few years. Total Current Liabilities is an item on Aadi Bioscience balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Aadi Bioscience are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Aadi Bioscience's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aadi Bioscience's overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Aadi Total Current Liabilities Regression Statistics
| Arithmetic Mean | 9,878,207 | |
| Geometric Mean | 2,069,829 | |
| Coefficient Of Variation | 113.89 | |
| Mean Deviation | 9,848,550 | |
| Median | 3,592,164 | |
| Standard Deviation | 11,250,064 | |
| Sample Variance | 126.6T | |
| Range | 30M | |
| R-Value | 0.84 | |
| Mean Square Error | 41.1T | |
| R-Squared | 0.70 | |
| Significance | 0.0001 | |
| Slope | 2,102,167 | |
| Total Sum of Squares | 1771.9T |
Aadi Total Current Liabilities History
About Aadi Bioscience Financial Statements
Investors use fundamental indicators, such as Aadi Bioscience's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Aadi Bioscience's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 26.4 M | 27.7 M |
Currently Active Assets on Macroaxis
When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock:Check out the analysis of Aadi Bioscience Correlation against competitors. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.28) | Revenue Per Share 0.929 | Quarterly Revenue Growth 0.21 | Return On Assets (0.35) | Return On Equity (0.66) |
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.